# Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER

> **NCT01857947** · NA · COMPLETED · sponsor: **ThermoFisher Scientific Brahms Biomarkers France** · enrollment: 370 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive Patients Admitted in Emergency Department for Acute Exacerbation

## Interventions

- **OTHER:** AECOPD Mr proADM

## Key facts

- **NCT ID:** NCT01857947
- **Lead sponsor:** ThermoFisher Scientific Brahms Biomarkers France
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2014-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857947, "Prognosis Value of Pro-adrenomedullin in Acute Exacerbations of COPD in ER". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01857947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*